Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 5.11
+0.04 (0.79%)
Last updated: Oct 22, 2025, 9:28 AM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €189.8 million as of October 22, 2025. Its market cap has decreased by -39.13% in one year.
Market Cap
189.80M
Enterprise Value
169.21M
Revenue
4.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.11
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 189.80M, a decrease of -54.57%. That is a compound annual growth rate of -14.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 189.80M | -38.61% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 48.58B |
| argenx SE | 44.55B |
| Financière de Tubize | 10.44B |
| Fagron NV | 1.55B |
| Ion Beam Applications | 328.96M |
| Onward Medical | 230.58M |
| Hyloris Pharmaceuticals | 157.36M |
| Sequana Medical NV | 47.54M |